Innovative Health Advances: From Brain-Computer Interfaces to RSV Vaccines | Health
Summary
Recent developments in healthcare showcase significant innovation and regulatory adjustments. China has approved the world’s first commercially available brain-computer interface (BCI) system, developed by Borui Kang Medical Technology, to assist paralyzed patients in regaining motor functions and communication. Simultaneously, GSK’s RSV vaccine, Arexvy, has received FDA approval for a wider age range, now including adults aged 18-49 with risk factors, to better combat respiratory illnesses. Beyond these advancements, legal settlements and regulatory decisions are shaping the landscape, including Viatris resolving a lawsuit with the family of Henrietta Lacks regarding the use of her cells in medical research, and the FDA’s cautious approach to vape products and sterilization gas regulations.
(Source:Devdiscourse)